ArticleCHEST pulmonary2026
A 48-Year-Old Woman With Shortness of Breath and a Recent Diagnosis of Breast Cancer.
Article in CHEST pulmonary, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 48-year-old perimenopausal woman presented to our hospital in May 2024 with New York Heart Association functional class III dyspnea and a dry cough. Her symptoms had been ongoing for several months but worsened significantly in the weeks before admission. She reported fatigue but denied other constitutional symptoms such as fever, weight loss, or night sweats. There was no orthopnea or paroxysmal nocturnal dyspnea, and she was not taking any medications at the time. She had recently been diagnosed with treatment naïve de novo metastatic left breast cancer, stage cT4bN3cM1, with metastasis to the lungs, liver, bilateral ovaries, and bones. The pathology confirmed invasive ductal carcinoma, grade 1, with estrogen receptor and progesterone receptor positivity and human epidermal growth factor receptor 2-negative status. On presentation, she had not yet received any cancer treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.